The use of cannabis to treat cystic fibrosis has been up for debate in recent years, but a team of neurologists and gastroenterologists at the University of Chicago want more evidence before they recommend its application. The doctors conducted an 8-week trial on patients with CF who were randomized into two groups: one group that took 10 milligrams per day (mg/d) delta9-tetrahydrocannabinol (THC), while another did not. They found THC could improve body weight, appetite and sleep quality among these adult patients.,
The top three recommended indications for usage were appetite, pain, and nausea.
A recent research from the United States indicates that healthcare professionals who treat people with cystic fibrosis (CF) should have a better knowledge of whether cannabis may help with symptoms.
Investigators came at this result after collecting responses from 282 survey participants from throughout the United States, with 28% of them being providers and 26% being social workers. Nurses, pharmacists, nutritionists, and members of the psychological care team were among the other professionals.
What exactly are twisties? Simone Biles reveals why she was forced to withdraw from the Olympics.
Researchers sought to ascertain whether respondents were aware of current cannabis legislation in their states, medical marijuana prescription procedures, screening and documentation processes, and understanding of and indications for which CBD might be helpful.
Only 15.4 percent of participants said they “always” assessed cannabis usage while dealing with CF patients, according to a research published last month. The majority of individuals surveyed, 48.4%, said they “occasionally” assessed marijuana usage, while 41% said they “rarely” or “never” did so.
A third of those polled, 35%, said they were either “slightly” or “not at all” prepared to address patient/family concerns regarding cannabis, while almost twice as many said they would be unable to do so with CBD.
Given that hunger, pain, and nausea were “the top three recommended indications for use,” the lack of information may be a problem for treatment.
According to the Cystic Fibrosis Foundation, some symptoms of the hereditary illness include chronic coughing, recurrent lung infections, and wheezing or shortness of breath.
Researchers believe “there is a need for care team and patient/caregiver teaching materials regarding cannabis/CBD and CF,” describing cannabis usage assessment, documentation, and education in CF treatment centers as varied.
According to Cystic Fibrosis News Today, having more educational resources regarding cannabis-based medicines and CF will “enable care providers to have informed dialogues with patients.” Future CF care team efforts should include the development of relevant, evidence-based, and peer-reviewed teaching materials, according to the researchers.
Another recent research, this time including medical students, highlights the lack of preparation. In comparison to their Thai counterparts, Israeli students felt unprepared to decide whether or not to use cannabis for pain treatment, according to a study.
Indeed, survey results published last year in The Journal of Primary Care & Community Health found that not many people believe doctors know what’s best when it comes to cannabis. Just 18 per cent of patients polled in Vermont, where medical marijuana has been legal since 2004, felt their physician was a good source of information about the drug.